{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T18:24:35Z","timestamp":1773080675356,"version":"3.50.1"},"reference-count":8,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jdcr.2025.10.062","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T05:08:45Z","timestamp":1762578525000},"page":"152-154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Paradoxical dyshidrosis following bimekizumab treatment for severe recalcitrant psoriasis"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-5078-2167","authenticated-orcid":false,"given":"Anagha B.","family":"Thiagarajan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7052-1173","authenticated-orcid":false,"given":"Luke","family":"Horton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3219-8253","authenticated-orcid":false,"given":"Bonnie A.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdcr.2025.10.062_bib1","doi-asserted-by":"crossref","first-page":"170","DOI":"10.7861\/clinmed.2021-0257","article-title":"Psoriasis: a brief overview","volume":"21","author":"Raharja","year":"2021","journal-title":"Clin Med (Lond)"},{"key":"10.1016\/j.jdcr.2025.10.062_bib2","first-page":"65","article-title":"Acrodermatitis continua of Hallopeau: clinical perspectives","volume":"9","author":"Smith","year":"2019","journal-title":"Psoriasis (Auckl)"},{"key":"10.1016\/j.jdcr.2025.10.062_bib3","doi-asserted-by":"crossref","DOI":"10.33590\/emjallergyimmunol\/10301362","article-title":"IL-17 and -23 inhibitors for the treatment of psoriasis","author":"Batta","year":"2023","journal-title":"EMJ Allergy Immunol"},{"key":"10.1016\/j.jdcr.2025.10.062_bib4","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.36849\/JDD.7388","article-title":"A case series of patients with eczematous eruptions following IL-17 inhibitor treatment for psoriasis vulgaris","volume":"22","author":"Yousif","year":"2023","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jdcr.2025.10.062_bib5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jamadermatol.2023.4846","article-title":"Risk of paradoxical eczema in patients receiving biologics for psoriasis","volume":"160","author":"Al-Janabi","year":"2024","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jdcr.2025.10.062_bib6","doi-asserted-by":"crossref","first-page":"563,9","DOI":"10.1016\/j.jaad.2004.04.012","article-title":"Evaluating psoriasis with psoriasis area and severity index, psoriasis global assessment, and lattice system physician's global assessment","volume":"51","author":"Langley","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jdcr.2025.10.062_bib7","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2022.2119767","article-title":"Review of bimekizumab in the treatment of psoriasis","volume":"18","author":"Koppu","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jdcr.2025.10.062_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-54559-6","article-title":"Immune modules to guide diagnosis and personalized treatment of inflammatory skin diseases","volume":"15","author":"Seremet","year":"2024","journal-title":"Nat Commun"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512625006034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512625006034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T08:31:35Z","timestamp":1768552295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512625006034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":8,"alternative-id":["S2352512625006034"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2025.10.062","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paradoxical dyshidrosis following bimekizumab treatment for severe recalcitrant psoriasis","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2025.10.062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}